Quadramet Drug Interactions
Currently displaying a list of 210 drugs known to interact with Quadramet (samarium sm 153 lexidronam).
- 190 major drug interactions
- 20 moderate drug interactions
Medications known to interact with Quadramet
Note: Showing generic names only.
A
- abemaciclib
- acalabrutinib
- afamitresgene autoleucel
- aldesleukin
- alemtuzumab
- altretamine
- asciminib
- atezolizumab
- avapritinib
- avelumab
- axicabtagene ciloleucel
- axitinib
- azacitidine
- azathioprine
B
- baricitinib
- belantamab mafodotin
- belinostat
- bendamustine
- bevacizumab
- bexarotene
- bleomycin
- blinatumomab
- bortezomib
- bosutinib
- brentuximab
- brexucabtagene autoleucel
- busulfan
C
- cabazitaxel
- cabozantinib
- capecitabine
- carboplatin
- carfilzomib
- carmustine
- cemiplimab
- chlorambucil
- chloramphenicol
- chloramphenicol ophthalmic
- chloramphenicol otic
- ciltacabtagene autoleucel
- cisplatin
- cladribine
- clofarabine
- clozapine
- cobimetinib
- copanlisib
- cosibelimab
- crizotinib
- cyclophosphamide
- cytarabine
D
- dacarbazine
- dactinomycin
- daratumumab
- dasatinib
- daunorubicin
- daunorubicin liposomal
- decitabine
- deucravacitinib
- dinutuximab
- docetaxel
- dostarlimab
- doxorubicin
- doxorubicin liposomal
- durvalumab
- duvelisib
E
- eflornithine
- elotuzumab
- elranatamab
- enfortumab vedotin
- epcoritamab
- epirubicin
- eribulin
- etidronate
- etoposide
F
G
H
I
- ibritumomab
- ibrutinib
- idarubicin
- idecabtagene vicleucel
- idelalisib
- ifosfamide
- imatinib
- imetelstat
- inavolisib
- inotuzumab ozogamicin
- interferon alfa-2a
- interferon alfa-2b
- interferon alfa-n1
- interferon alfacon-1
- interferon gamma-1b
- iobenguane I 131
- iodine i 131 tositumomab
- ipilimumab
- irinotecan
- irinotecan liposomal
- isatuximab
- ixabepilone
- ixazomib
L
- lenalidomide
- levamisole
- lifileucel
- lisocabtagene maraleucel
- lomustine
- loncastuximab tesirine
- lurbinectedin
- lutetium lu 177 dotatate
- lutetium lu 177 vipivotide tetraxetan
M
- mechlorethamine
- melphalan
- melphalan flufenamide
- mercaptopurine
- methotrexate
- midostaurin
- mitomycin
- mitotane
- mitoxantrone
- mogamulizumab
- momelotinib
- mosunetuzumab
N
O
- obecabtagene autoleucel
- obinutuzumab
- ocrelizumab
- ofatumumab
- olaparib
- omacetaxine
- osimertinib
- oxaliplatin
P
- paclitaxel
- paclitaxel protein-bound
- palbociclib
- panobinostat
- pazopanib
- peginterferon alfa-2a
- peginterferon alfa-2b
- pembrolizumab
- pemetrexed
- pentostatin
- plicamycin
- polatuzumab vedotin
- pomalidomide
- ponatinib
- pralatrexate
- procarbazine
- promazine
Q
R
- retifanlimab
- revumenib
- ribociclib
- ritlecitinib
- rituximab
- romidepsin
- ropeginterferon alfa-2b
- rucaparib
- ruxolitinib
S
T
- tafasitamab
- talazoparib
- talquetamab
- teclistamab
- temozolomide
- teniposide
- thalidomide
- thioguanine
- thiotepa
- tisagenlecleucel
- tislelizumab
- tisotumab vedotin
- tofacitinib
- topotecan
- toripalimab
- tositumomab
- trabectedin
- trastuzumab
- tremelimumab
- treosulfan
- trimetrexate
U
V
Z
Report options
QR code containing a link to this page
More about Quadramet (samarium sm 153 lexidronam)
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.